Array BioPharma Company Profile (NASDAQ:ARRY)

About Array BioPharma

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer. The Company's wholly owned clinical stage drugs include Filanesib in Phase II clinical trials, is indicated for Kinesin spindle protein (KSP), inhibitor for MM; ARRY-797 in Phase II clinical trials, indicated for p38 inhibitor for Lamin A/C-related dilated cardiomyopathy (LMNA-DCM); ARRY-502 in Phase II clinical trials, indicated for CRTh2 antagonist for asthma, and ARRY-614 in Phase I clinical trials, is indicated for p38/Tie2 dual inhibitor for myelodysplastic syndromes (MDS). In addition, the Company has 11 ongoing partner-funded clinical programs, including two MEK inhibitors, which are both in Phase III clinical trials, binimetinib with Novartis and selumetinib with AstraZeneca.

Industry, Sector and Symbol:

Sector: Medical
Industry: Biotechnology
Sub-Industry: Biotechnology
Exchange: NASDAQ
Symbol: ARRY
CUSIP: 04269X10

Key Metrics:

Previous Close: $6.59
50 Day Moving Average: $3.76
200 Day Moving Average: $3.45
52-Week Range: $2.38 - $7.27
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -9.96
P/E Growth: -0.90
Market Cap: $910.74M
Outstanding Shares: 145,022,000
Beta: 2.11

Profitability:

Net Margins: -67.33%
Return on Equity: -568.67%
Return on Assets: -49.40%

Debt:

Debt-to-Equity Ratio: -3.00%
Current Ratio: 2.96%
Quick Ratio: 2.96%

Additional Links:

Companies Related to Array BioPharma:

Consensus Ratings for Array BioPharma (NASDAQ:ARRY) (?)

Ratings Breakdown:	7 Buy Ratings
Consensus Rating:	Buy (Score: 3.00)
Consensus Price Target:	$9.00 (43.43% upside)

Analysts' Ratings History for Array BioPharma (NASDAQ:ARRY)

Show:

Date	Firm	Action	Rating	Price Target
9/27/2016	JPMorgan Chase & Co.	Reiterated Rating	Overweight	$6.00 -> $8.00
9/27/2016	Jefferies Group	Boost Price Target	Buy -> Buy	$7.00 -> $8.00
9/26/2016	Cantor Fitzgerald	Reiterated Rating	Buy	$13.00
9/26/2016	Leerink Swann	Boost Price Target	Overweight -> Outperform	$6.00 -> $9.00
9/26/2016	Piper Jaffray Cos.	Boost Price Target	Overweight	$7.00 -> $10.00
8/5/2016	Stifel Nicolaus	Boost Price Target	Buy	$7.00 -> $8.00
6/2/2016	SunTrust Banks Inc.	Initiated Coverage	Buy	$7.00

(Data available from 9/29/2014 forward)

Earnings History for Array BioPharma (NASDAQ:ARRY)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
11/2/2016
8/4/2016	Q416	($0.14)	($0.16)	$41.51 million	$43.20 million	View	Listen
5/3/2016	Q316	($0.12)	($0.16)	$30.35 million	$43.00 million	View	Listen
2/2/2016	Q216	($0.06)	($0.17)	$32.70 million	$35.40 million	View	Listen
11/4/2015	Q116	($0.18)	($0.15)	$14.02 million	$16.20 million	View	Listen
8/3/2015	Q415	($0.16)	($0.09)	$10.29 million	$12.30 million	View	Listen
5/4/2015	Q315	($0.01)	$0.37	$6.00 million	$6.60 million	View	Listen
2/3/2015	Q215	($0.18)	($0.06)	$10.20 million	$26.92 million	View	Listen
11/4/2014	Q115	($0.22)	($0.21)	$6.35 million	$6.07 million	View	Listen
8/12/2014	Q414	($0.23)	($0.22)	$8.10 million	$6.00 million	View	Listen
4/29/2014	Q314	($0.21)	($0.20)	$9.40 million	$7.80 million	View	Listen
2/4/2014	Q214	($0.16)	($0.13)	$13.49 million	$14.10 million	View	Listen
10/31/2013	Q114	($0.18)	($0.13)	$11.20 million	$14.20 million	View	Listen
8/7/2013	Q4 2013	($0.13)	($0.06)	$16.13 million	$25.40 million	View	Listen
5/6/2013	Q3 2013	($0.14)	($0.19)	$14.54 million	$10.00 million	View	Listen
2/4/2013	Q2 2013	($0.14)	($0.10)	$16.52 million	$18.40 million	View	Listen
10/29/2012	Q113	($0.15)	($0.13)	$16.70 million	$15.80 million	View	N/A
8/13/2012		($0.11)	($0.09)			View	N/A
4/30/2012		($0.16)	($0.11)			View	N/A
1/30/2012		($0.12)	($0.06)			View	N/A
5/2/2011		($0.25)	($0.20)			View	N/A
1/31/2011		($0.28)	($0.23)			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Array BioPharma (NASDAQ:ARRY)

Current Year EPS Consensus Estimate: $-0.82 EPS
Next Year EPS Consensus Estimate: $-0.63 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	3	($0.18)	($0.15)	($0.16)
Q2 2016	3	($0.18)	($0.14)	($0.16)
Q4 2016	3	($0.27)	$0.09	($0.13)
Q1 2017	2	($0.22)	($0.21)	($0.22)
Q2 2017	2	($0.27)	($0.22)	($0.25)
Q3 2017	2	($0.26)	($0.24)	($0.25)
Q4 2017	2	($0.34)	($0.19)	($0.27)

(Data provided by Zacks Investment Research)

Dividend History for Array BioPharma (NASDAQ:ARRY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Array BioPharma (NASDAQ:ARRY)

Insider Ownership Percentage: 2.60%
Institutional Ownership Percentage: 85.92%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
9/15/2016	Redmile Group, Llc	Major Shareholder	Buy	400,000	$3.51	$1,404,000.00
1/20/2016	Redmile Group, Llc	Major Shareholder	Buy	300,000	$3.19	$957,000.00
1/12/2016	Redmile Group, Llc	Major Shareholder	Buy	75,000	$3.60	$270,000.00
1/11/2016	Redmile Group, Llc	Major Shareholder	Buy	925,000	$3.67	$3,394,750.00
10/1/2015	Redmile Group, Llc	Major Shareholder	Buy	782,592	$4.58	$3,584,271.36
8/25/2015	Redmile Group, Llc	Major Shareholder	Buy	790,000	$5.38	$4,250,200.00
8/10/2015	Redmile Group, Llc	Major Shareholder	Buy	1,048,993	$5.80	$6,084,159.40
3/3/2015	Kyle Lefkoff	Director	Sell	70,000	$8.00	$560,000.00
3/2/2015	Andrews R Robbins	SVP	Sell	21,576	$8.25	$178,002.00
3/2/2015	Ron Squarer	CEO	Sell	40,000	$8.25	$330,000.00
9/16/2013	Liam Ratcliffe	Director	Sell	1,673,172	$6.08	$10,172,885.76
9/6/2013	Liam Ratcliffe	Director	Sell	577,286	$5.79	$3,342,485.94
8/2/2013	John R Moore	VP	Sell	75,384	$7.02	$529,195.68
7/23/2013	John R Moore	VP	Sell	5,000	$6.50	$32,500.00

(Data available from 1/1/2013 forward)

Latest Headlines for Array BioPharma (NASDAQ:ARRY)

Date	Headline
	Array BioPharma Inc. (NASDAQ:ARRY) Insider Trading Report - Newburgh Press (NASDAQ:ARRY) newburghpress.com - September 29 at 8:23 AM
	Array BioPharma Announces Pricing of Public Offering of Common Stock - PR Newswire (press release) (NASDAQ:ARRY) www.prnewswire.com - September 29 at 8:23 AM
	Overbuying Alert on: Array Biopharma Inc (NASDAQ:ARRY) - Post Registrar (NASDAQ:ARRY) postregistrar.com - September 29 at 8:23 AM
	Array BioPharma Reports Positive Results (ARRY) - Investopedia (NASDAQ:ARRY) www.investopedia.com - September 29 at 8:23 AM
	JP Morgan Hikes Price Target on Array BioPharma Inc (ARRY) Following Positive COLUMBUS Phase 3 Results - Smarter Analyst (NASDAQ:ARRY) www.smarteranalyst.com - September 28 at 3:32 PM
	Array Biopharma (ARRY) Prices 18.4M Share Stock Offering for Proceeds of ~$115M - StreetInsider.com (NASDAQ:ARRY) www.streetinsider.com - September 28 at 8:22 AM
	Analysts Valuations For Two Stocks: Real Gds Solar (SWX:RGSE), Array Biopharma Inc (NASDAQ:ARRY) - The Voice Registrar (NASDAQ:ARRY) voiceregistrar.com - September 28 at 8:22 AM
	Array BioPharma Announces Pricing of Public Offering of Common Stock (NASDAQ:ARRY) www.publicnow.com - September 28 at 8:22 AM
	2:40 am Array Biopharma prices offering of 18.4 mln shares of its common stock at $6.25 per share (NASDAQ:ARRY) finance.yahoo.com - September 28 at 8:22 AM
	Array BioPharma prices upsized equity offering at $6.25 (NASDAQ:ARRY) seekingalpha.com - September 28 at 7:39 AM
	Array BioPharma launches $100M equity offering; shares off 4% after hours (NASDAQ:ARRY) seekingalpha.com - September 27 at 6:45 PM
	Biotech Stocks Worth Chasing: PDL BioPharma, Inc. (PDLI), Array BioPharma Inc. (ARRY) - The Independent Republic (NASDAQ:ARRY) theindependentrepublic.com - September 27 at 3:34 PM
	Biotech Stocks Worth Chasing: PDL BioPharma, Inc. (PDLI), Array BioPharma Inc. (ARRY) - The Independent Republic (NASDAQ:ARRY) theindependentrepublic.com - September 27 at 3:34 PM
	Analyst Upgrades: Twitter Inc, Array Biopharma Inc, and Eli Lilly and Co - Schaeffers Research (blog) (NASDAQ:ARRY) www.schaeffersresearch.com - September 27 at 3:34 PM
	Analyst Upgrades: Twitter Inc, Array Biopharma Inc, and Eli Lilly and Co - Schaeffers Research (blog) (NASDAQ:ARRY) www.schaeffersresearch.com - September 27 at 3:34 PM
	3 Stocks to Watch Tuesday: Kite Pharma Inc (KITE), Array Biopharma Inc (ARRY) and Mylan NV (MYL) - Investorplace.com (NASDAQ:ARRY) investorplace.com - September 27 at 3:34 PM
	3 Stocks to Watch Tuesday: Kite Pharma Inc (KITE), Array Biopharma Inc (ARRY) and Mylan NV (MYL) - Investorplace.com (NASDAQ:ARRY) investorplace.com - September 27 at 3:34 PM
	Array Biopharma Inc (ARRY) Surges 60% as Shorts Get Squeezed - Investorplace.com (NASDAQ:ARRY) investorplace.com - September 27 at 8:07 AM
	Trading the Biotech News: BioTime, Inc. (NYSEMKT:BTX), Array BioPharma Inc. (NASDAQ:ARRY) - The Voice Registrar (NASDAQ:ARRY) voiceregistrar.com - September 26 at 3:36 PM
	Healthcare Analysts Change Price Targets on Array Biopharma Inc (ARRY) and Incyte Corporation (INCY) - Smarter Analyst (NASDAQ:ARRY) www.smarteranalyst.com - September 26 at 3:36 PM
	Why Investors Are Buzzing About Yum, Twitter, GM, RetailMeNot, and Array Biopharma Today (NASDAQ:ARRY) www.insidermonkey.com - September 26 at 3:36 PM
	Why Array BioPharma Inc Is Surging Today (NASDAQ:ARRY) www.fool.com - September 26 at 12:37 PM
	Array BioPharma and Pierre Fabre Announce COLUMBUS Phase 3 Study of Encorafenib plus Binimetinib For BRAF-Mutant Melanoma Met Primary Endpoint (NASDAQ:ARRY) www.publicnow.com - September 26 at 8:16 AM
	Biotech stocks for your portfolio: Array BioPharma Inc. (ARRY), Celldex Therapeutics, Inc. (CLDX) - The Independent Republic (NASDAQ:ARRY) theindependentrepublic.com - September 23 at 3:59 PM
	Biotech Stocks To Put On Your Watch List: PDL BioPharma, Inc. (NASDAQ:PDLI), Array BioPharma Inc. (NASDAQ:ARRY) - The Voice Registrar (NASDAQ:ARRY) voiceregistrar.com - September 22 at 3:34 PM
	Biotech stocks for your portfolio: Array BioPharma (ARRY), Alexion Pharmaceuticals (ALXN) - The Independent Republic (NASDAQ:ARRY) theindependentrepublic.com - September 22 at 3:34 PM
	Analysts Valuations For Two Stocks: Navistar International Corp (NYSE:NAV), Array Biopharma Inc (NASDAQ:ARRY) - The Voice Registrar (NASDAQ:ARRY) voiceregistrar.com - September 22 at 3:34 PM
	Array BioPharma Inc.'s (ARRY) - Cosumnes Connection (subscription) (NASDAQ:ARRY) www.crcconnection.com - September 21 at 8:40 AM
	Advancing Preclinical Autoimmune Studies & Accelerated FDA Approvals Producing Rewards in Biotech Sector (NASDAQ:ARRY) ih.advfn.com - September 20 at 3:34 PM
	First Week of ARRY November 18th Options Trading (NASDAQ:ARRY) www.stockoptionschannel.com - September 20 at 3:34 PM
	Scorching Hot Biotech Stocks Tape: Array BioPharma Inc. (ARRY ... - The Independent Republic (NASDAQ:ARRY) theindependentrepublic.com - September 20 at 9:31 AM
	Array BioPharma Inc. (NASDAQ:ARRY) Upgrades/Downgrades Update - Newburgh Press (NASDAQ:ARRY) newburghpress.com - September 20 at 9:31 AM
	Array BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : ARRY-US : September 20, 2016 (NASDAQ:ARRY) www.capitalcube.com - September 20 at 9:31 AM
	HC Stocks Midpoint! Brookdale Senior Living, Inc. (BKD), Array Biopharma Inc (NASDAQ:ARRY) - share market updates (press release) (NASDAQ:ARRY) sharemarketupdates.com - September 19 at 8:23 AM
	10 Analyst Stock Picks Under $10 for Massive Upside - 24/7 Wall St. (NASDAQ:ARRY) 247wallst.com - September 18 at 3:33 PM
	Array BioPharma : Announces FDA Acceptance of Binimetinib NDA for Patients with Advanced NRAS-Mutant Melanoma (NASDAQ:ARRY) www.4-traders.com - September 17 at 3:35 PM
	Biotech news that matter for investors: ZIOPHARM Oncology, Inc ... - The Voice Registrar (NASDAQ:ARRY) voiceregistrar.com - September 17 at 8:23 AM
	2 Sizzling Hot Biotechnology Stocks: Array BioPharma Inc. (ARRY), ZIOPHARM Oncology, Inc. (ZIOP) - The Independent Republic (NASDAQ:ARRY) theindependentrepublic.com - September 16 at 3:34 PM
	Array Secures SPA Agreement With FDA for Colorectal Cancer Trial ... - Investopedia (NASDAQ:ARRY) www.investopedia.com - September 15 at 3:33 PM
	ARRAY BIOPHARMA INC : Other Events, Financial Statements and Exhibits (form 8-K) (NASDAQ:ARRY) www.4-traders.com - September 15 at 12:29 PM
	Array Secures SPA Agreement With FDA for Colorectal Cancer Trial (ARRY) (NASDAQ:ARRY) www.investopedia.com - September 14 at 8:49 PM
	HC Stocks in Hub= Array Biopharma Inc (ARRY), Sarepta Therapeutics Inc (NASDAQ:SRPT) - share market updates (press release) (NASDAQ:ARRY) sharemarketupdates.com - September 14 at 3:36 PM
	Array BioPharma Announces Phase 3 BEACON CRC SPA Agreement with FDA (NASDAQ:ARRY) finance.yahoo.com - September 14 at 7:42 AM
	ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:ARRY) biz.yahoo.com - September 14 at 7:42 AM
	Why Array Biopharma May Become a Winner (ARRY) - Investopedia (NASDAQ:ARRY) www.investopedia.com - September 13 at 3:35 PM
	Why Array Biopharma May Become a Winner (ARRY) (NASDAQ:ARRY) www.investopedia.com - September 12 at 3:34 PM
	How To Approach Momentum Trading Like A Pro (NASDAQ:ARRY) www.investopedia.com - September 12 at 8:21 AM
	Array BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : ARRY-US : September 9, 2016 (NASDAQ:ARRY) www.capitalcube.com - September 9 at 8:23 AM
	Two Biotech Stocks Are Just So Hot Right Now: Array BioPharma (ARRY), Intrexon (XON) - The Independent Republic (NASDAQ:ARRY) theindependentrepublic.com - September 7 at 8:43 PM
	Array Plays The Cardiovascular Card - Seeking Alpha (NASDAQ:ARRY) seekingalpha.com - September 7 at 12:38 PM